Page: 10 of 30 6 7 8 9 10 11 12 13 14

Dr Paul Cornes, Bristol Oncology Centre, UK Channel: www.ecancer.tv Length: 0 Date: August 03, 2010 Dr Cornes speaks about an e-learning facility used to share information among oncologists in Asia. Experts give lessons in the radiotherapy best pr...

Dr Paul Cornes, Bristol Oncology Centre, UK Channel: www.ecancer.tv Length: 0 Date: August 03, 2010 Dr Cornes discusses how the health service will cope with the costs associated with rapidly rising cancer rates. Dr Cornes speaks about the role cl...

Dr Stephen Baylin, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA Channel: www.ecancer.tv Length: 0 Date: August 03, 2010 Dr Stephen Baylin speaks at an EHA 2010 press conference about the use of epigenetics to treat cancer. Dr Baylin explains what epigenetics is, tal...

Prof Gilles Salles, Centre Hospitalier Lyon-Sud, France Channel: www.ecancer.tv Length: 0 Date: August 03, 2010 Prof Gilles Salles speaks at an EHA 2010 press conference about the PRIMA study which has shown that retuximab 'maintenance' ther...

Dr Michael Huo, University of Texas Southwestern Medical Center, USA Channel: www.ecancer.tv Length: 0 Date: August 03, 2010 Dr Michael Huo speaks at an EHA 2010 press conference about a phase III prospective study comparing the dabigatran etexilate 220mg with enoxaparin ...

Prof Robin Foà, Sapienza University of Rome, Italy Channel: www.ecancer.tv Length: 0 Date: August 03, 2010 Prof Robin Foà talks about the increasing importance of the annual EHA congress, not just within Europe but across the world. The 2010 Barcelona c...

Dr Siow Ming Lee, University College London, UK Channel: www.ecancer.tv Length: 0 Date: August 03, 2010 Dr Lee speaks about the TOPICAL trial, a randomised phase III trial of erlotinib in chemotherapy-naive patients with advanced non-small cell lung ...

Dr Rachel Iredale, Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz Channel: www.ecancer.tv Length: 0 Date: July 26, 2010 At the time of your diagnosis did you feel you had sufficient information to make informed decisions?Would it have been helpful to have been given ...

Dr Rachel Iredale, Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz Channel: www.ecancer.tv Length: 0 Date: July 26, 2010 What are the implications of knowing you are a gene carrier and how can you be better supported?For the women in these clips, discovering that the...

Dr Rachel Iredale, Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz Channel: www.ecancer.tv Length: 0 Date: July 26, 2010 If you had to pick one thing that you think would improve risk communication what would it be? How can we speed up the process of adoption of best ...

Dr Rachel Iredale, Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz Channel: www.ecancer.tv Length: 0 Date: July 26, 2010 Who are the health professionals generally involved in communicating genetic risk in your country? Does it vary and are they the right people?What ...

Dr Rachel Iredale, Prof Lesley Fallowfield, Carol Maddock, Maureen Gilbert, Cathie Lockenwitz, Francisca Bach Kolling – Dandrieu and Roswitha Britz Channel: www.ecancer.tv Length: 0 Date: July 26, 2010 What advice or support about how to tell other members of your family about being a gene carrier were you given? What works well?

Prof Tony Goldstone, Imperial College London, UK Channel: www.ecancer.tv Length: 0 Date: July 26, 2010 Prof Goldstone talks about the UKALL trials investigating treatment options for patients with ALL. These trials have compared allograft, the use o...

Dr Steve Johnson Channel: www.ecancer.tv Length: 0 Date: July 26, 2010 Dr Johnson talks about the communication skills workshop he chaired at EHA 2010 and explains how good communication skills benefit both clinicians ...

Prof Stephen O’Brien, Newcastle University UK Channel: www.ecancer.tv Length: 0 Date: July 26, 2010 Prof O’Brien discusses the idea he proposed at the 2010 EHA congress: 'Patients should be 'forced' to enter clinical tri...

Professor Robert Coleman, Weston Park Hospital, Sheffield, UK Channel: www.ecancer.tv Length: 0 Date: July 23, 2010 Professor Robert Coleman speaks about the side effects experienced by patients with cancer of the bone and discusses how denosumab, zoledronic aci...

Professor Robert Coleman, Weston Park Hospital, Sheffield, UK Channel: www.ecancer.tv Length: 0 Date: July 23, 2010 Professor Robert Coleman talks about zoledronic acid, other bisphosphonates and denosumab, the mechanism through which these drugs affect cancers ...

Professor Robert Coleman, Weston Park Hospital, Sheffield, UK Channel: www.ecancer.tv Length: 0 Date: July 23, 2010 Peter Goodwin speaks to Professor Robert Coleman about targeted therapy, specifically treatment that targets bone metastases. Prof Coleman explain...

Professor Jesús San-Miguel - University Hospital of Salamanca, Spain Channel: www.ecancer.tv Length: 0 Date: July 23, 2010 Prof Jesús San-Miguel talks about the progression in myeloma survival rates and the contributing factors. Data from a large randomised trial is sho...

Dr Tony Goldstone, Imperial College London, UK Channel: www.ecancer.tv Length: 0 Date: July 22, 2010 Dr Goldstone talks about the UKALL trials investigating treatment options for patients with ALL. These trials have compared allograft, the use of ...

Page: 10 of 30 6 7 8 9 10 11 12 13 14